SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LIPO-Liposome -- Ignore unavailable to you. Want to Upgrade?

To: Dr. Seuss who wrote (829)9/16/1999 7:26:00 PM
From: Brian Malloy  Respond to of 900
 
Unfortunately I think it will be a case of how low can we go. Since this is a biotech, I would expect it to get whacked a minimum of 1/3 so it will open in all likelihood at ~ $12 or less. The market doesn't like bad news or news perceived as bad. Even first tier companies like ORCL and FDX get ravaged in this market.

IMHO



To: Dr. Seuss who wrote (829)9/16/1999 9:15:00 PM
From: get shorty  Read Replies (2) | Respond to of 900
 
Doc:

I was short SNRS going into their FDA review and
they also were rejected. They lost 75% of their
market cap. overnight. It was a momo play running
into the panel review but I still actually felt sorry
for the longs.

I missed the LIPO play. Mr. Goldfinger called it, but
I didn't have the cajones to play this one. I'm glad
you got a piece of this one!

Regards,
shorty


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News